Tag: Staging
-
PSMA-PET/CT May Replace NaF-PET/CT in Advanced Prostate Cancer
PSMA-PET/CT Could Redefine Staging in High-Risk Prostate Cancer Imaging plays a pivotal role in determining treatment for men with newly diagnosed, high-risk prostate cancer. A recent Danish study suggests that replacing the conventional F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA-PET/CT could significantly alter metastatic staging and, in turn, treatment decisions. The findings, published in…
-
PSMA-PET/CT Could Replace NaF-PET/CT in Advanced Prostate Cancer
New Evidence Supports a Shift in Prostate Cancer Imaging Researchers in Denmark have found that replacing F-18 sodium fluoride (NaF) PET/CT with F-18 prostate-specific membrane antigen (PSMA) PET/CT could meaningfully influence treatment decisions for men with newly diagnosed high-risk prostate cancer. In a prospective, within-patient comparison, the study suggests that PSMA-PET/CT not only improves diagnostic…